EKKO- A Wave Therapeutic Device
“EKKO-Wave Therapeutic Device” provides a new solution for cognitive rehabilitation using vibrational waves.
EKKO is a portable device which uses non-invasive vibrational waves to treat neurological disorders based on Neurotransmission Cognitive Theory. Vibrational waves have been found to be effective in the fast recovery of muscles because of their resonance with the natural frequencies of the muscle fibers and are already used in the medical industry.
A complete product from research to development EKKO is now available in two versions: EKKO Portable (for use at homes) and EKKO Clinic (for specific use at hospitals/ healthcare clinics).
The product includes two modules:
Vibration wave therapy device: The device is based on neurotransmission cognitive theory, is portable, produces customizable vibration frequencies, and operates in both manual and intelligent software modes for personalized rehabilitation.
Intelligent assistant software with cloud services: The software integrates data from surveys, clinical results, feedback, and trend analysis into a knowledge-based decision support system for patient self-rehabilitation. This product can be used at home by parents of special children and at special education centers for rehabilitation of special children.
PRIMARY GOAL
EKKO aims to make disabled children and those with treatable neural disorders, such as speech and movement disorders, a respected member of society by providing a rehabilitation method that is simple, accessible and has no side effects.
BACKGROUND
Rehabilitation is the action of restoring someone to healthy and normal life through training and therapy after some illness so that he/she may attain a useful and constructive place in society. Many diseases affect children in the modern day in their childhood and some at birth. These diseases include behavioral, neural, and physical disorders. Some of the prominent disorders include Sensory Dysfunction Disorder (SDD), Stereotypic Movement Disorder (SMD), Cerebral Palsy (CP), Muscle Atrophy/Local Atrophy, Tongue Neuropathy, Squint (strabismus), Childhood apraxia of speech (CAS) and Dysarthria.
STATISTICS OF NEUROLOGICAL DISORDERS
Neurological disorders are most common among children. They have affected over 1 billion people worldwide with 20 million people affected in Pakistan leading to 12% deaths worldwide. globally, 1/323 children suffer from Cerebral Palsy making a total of 18 million people, 1/68 children suffer from Autism Spectrum Disorder making a total of around 75 million people, 1/25 children suffers from Stereotypic Movement Disorder, and 1/36 children suffers from Squint.
AVAILABLE THERAPIES
- Electroconvulsive Therapy
- Environmental Therapy
- Prescription Drugs
- Chiropractors
- Vibrational Waves
- Occupational Therapy
NEUROTRANSMISSION COGNITIVE THEORY
Decades of work has been poured into cognitive rehabilitation and a number of different therapies and medications are available in the market for their treatment. The use of vibrational waves has been neglected entirely in this area. Existing therapy devices uses vibrations waves but only for physical rehabilitation. There is no single device in the market that targets cognitive rehabilitation.
The market is ripe for an innovative and accessible solution. What makes EKKO unique is Neurotransmission cognitive theory developed by Dr. Shahbaz Khalid Ranjha with following features:
- Brain Death: A shock experienced by the brain could not always be elaborated as a brain death.
- Alive Brain Cells: The affected brain cells may stay alive with reduced blood supply.
- Mal Cognitive Maps: Mal/ defective cognitive maps can be developed through neurons lying ineffective.
- Reactivation of Maps: At preliminary stage, natural pathways can be reactivated through vibration waves gadgets.
- Vibrational Waves: Simple mechanical vibrational waves are the source of stimulation.
WORK-FLOW OF EKKO
CLINICAL TRIALS
Clinical trials have proven EKKO efficacy to overcome symptoms like:
- Tongue dysarthria
- Motor speech aphasia / dysphasia
- Tongue apraxia, facial palsy
- Fine motor movements
- Drooling
- Chewing disorders
Currently, there are over 114 active patients with 1623 therapy sessions.
GREAT MINDS BEHIND THE RESEARCH & DEVELOPMENT OF EKKO
Dr. Shahbaz Khalid Ranjha, Director (Directorate General of Special Education) Psychologist & Speech Therapist (Family Health Hospital)
Mr. Ali Saeed Khan, CEO RISETech
Dr. Muhammad Usman Akram, Medical Image/Signal Processing, AI Co-Founder & Chief Scientist, RISETech
Dr. Sajid Gul Khawaja, Embedded Systems and Artificial Intelligence Co-Founder & Chief Scientist, RISETech
RECOGNITION & AWARDS
EKKO has received over 12 awards and nation-wide recognition for its innovative research and implementation in the areas of:
- Cognitive Rehabilitation
- Neurotransmission Cognitive Theory
- Portable Design
by Startup Weekend, Pasha, FICS, JUMP, Kamyab, Falling Walls Lab, COMPPEC 2018, Best IT Innovation award 2017, EME Centre of Innovation & Entrepreneurship, NUST, HEC, CEME.
TESTIMONIALS FROM PARENTS OF PATIENTS USING EKKO
“We’ve noticed a significant improvement in our son’s behaviour; he can now speak clearly, his hands’ muscles have strengthened and his writing/drawing skills have improved. We are very happy with the overall experience and the responsiveness of the team”.
“There is a significant improvement in the responsiveness of child, he is now able to follow our commands, understanding is better and he behaves very well. We are satisfied with the experience and behavior of the team”.
“There is a noticeable improvement in the patience and sleeping pattern of the child. Now, he is able to carry out a few activities on command, behavior has also improved. We are satisfied with the experience and behavior of the team”.
“Our child’s body balance has improved, he’s more active and able to grip things firmly. His memory has improved and his observation and eye contact are better than before. We are satisfied with the experience and behavior of the team”.
